{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:44:21Z","timestamp":1794469461379,"version":"4.9.1"},"reference-count":52,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2026.0032","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T09:42:57Z","timestamp":1778146977000},"source":"Crossref","is-referenced-by-count":2,"title":["ADHD in children, adolescents, and adults: incidence, prevalence, and treatment. An analysis of routine health insurance data"],"prefix":"10.3238","author":[{"given":"Felix","family":"Betzler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Gr\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Timpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vukasin","family":"Viskovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sch\u00f6ttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"10.3238\/arztebl.m2026.0032_ref1","doi-asserted-by":"crossref","unstructured":"Posner J, Polanczyk GV, Sonuga-Barke E: Attention-deficit hyperactivity disorder. Lancet 2020; 395 (10222): 450\u201362.","DOI":"10.1016\/S0140-6736(19)33004-1"},{"key":"10.3238\/arztebl.m2026.0032_ref2","doi-asserted-by":"crossref","unstructured":"Cortese S, Bellgrove MA, Brikell I, et al.: Attention-deficit\/hyperactivity disorder (ADHD) in adults: Evidence base, uncertainties and controversies. World Psychiatry 2025; 24: 347\u201371.","DOI":"10.1002\/wps.21374"},{"key":"10.3238\/arztebl.m2026.0032_ref3","doi-asserted-by":"crossref","unstructured":"Bachmann CJ, Philipsen A, Hoffmann F: ADHD in Germany: Trends in diagnosis and pharmacotherapy\u2014a country-wide analysis of health insurance data on attention-deficit\/hyperactivity disorder (ADHD) in children, adolescents and adults from 2009\u20132014. Dtsch Arztebl Int 2017; 114: 141\u20138.","DOI":"10.3238\/arztebl.2017.0141"},{"key":"10.3238\/arztebl.m2026.0032_ref4","doi-asserted-by":"crossref","unstructured":"Popit S, Serod K, Locatelli I, Stuhec M: Prevalence of attention-deficit hyperactivity disorder (ADHD): Systematic review and meta-analysis. Eur Psychiatry 2024; 67: e68.","DOI":"10.1192\/j.eurpsy.2024.1786"},{"key":"10.3238\/arztebl.m2026.0032_ref5","unstructured":"G\u00f6bel K, Baumgarten F, Kuntz B, H\u00f6lling H, Schlack R: ADHD in children and adolescents in Germany. Results of the cross-sectional KiGGS Wave 2 study and trends. J Health Monit 2018; 3: 42\u20139."},{"key":"10.3238\/arztebl.m2026.0032_ref6","doi-asserted-by":"crossref","unstructured":"Sibley MH, Swanson JM, Arnold LE, et al.: Defining ADHD symptom persistence in adulthood: Optimizing sensitivity and specificity. J Child Psychol Psychiatry 2017; 58: 655\u201362.","DOI":"10.1111\/jcpp.12620"},{"key":"10.3238\/arztebl.m2026.0032_ref7","doi-asserted-by":"crossref","unstructured":"Cortese S, Song M, Farhat LC, et al.: Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: Data, with critical re-analysis, from the Global Burden of Disease study. Mol Psychiatry 2023; 28: 4823\u201330.","DOI":"10.1038\/s41380-023-02228-3"},{"key":"10.3238\/arztebl.m2026.0032_ref8","unstructured":"Edition F: Diagnostic and statistical manual of mental disorders. Am Psychiatric Assoc 2013; 21: 591\u2013643."},{"key":"10.3238\/arztebl.m2026.0032_ref9","doi-asserted-by":"crossref","unstructured":"Ayano G, Tsegay L, Gizachew Y, et al.: Prevalence of attention deficit hyperactivity disorder in adults: Umbrella review of evidence generated across the globe. Psychiatry Res 2023; 328: 115449.","DOI":"10.1016\/j.psychres.2023.115449"},{"key":"10.3238\/arztebl.m2026.0032_ref10","unstructured":"(NICE) NIfHaCE: Attention deficit hyperactivity disorder: Diagnosis and management. NICE Clinical guideline NG87. London: NICE; 2018."},{"key":"10.3238\/arztebl.m2026.0032_ref11","unstructured":"(AWMF) AdWMF: Langfassung der interdisziplin\u00e4ren evidenz- und konsensbasierten (S3) Leitlinie \u201eAufmerksamkeitsdefizit-\/Hyperaktivit\u00e4tsst\u00f6rung (ADHS) im Kindes-, Jugend- und Erwachsenenalter\u201c 2018. www.register.awmf.org\/assets\/guidelines\/028\u2013045l_S3_ADHS_2018\u201306-abgelaufen.pdf (last accessed on 24 August 2025)."},{"key":"10.3238\/arztebl.m2026.0032_ref12","doi-asserted-by":"crossref","unstructured":"Coghill D, Banaschewski T, Cortese S, et al.: The management of ADHD in children and adolescents: Bringing evidence to the clinic: Perspective from the European ADHD Guidelines Group (EAGG). Eur Child Adolesc Psychiatry 2023; 32: 1337\u201361.","DOI":"10.1007\/s00787-021-01871-x"},{"key":"10.3238\/arztebl.m2026.0032_ref13","doi-asserted-by":"crossref","unstructured":"Storeb\u00f8 OJ, Storm MRO, Pereira Ribeiro J, et al.: Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev 2025; 12: Cd009885.","DOI":"10.1002\/14651858.CD009885.pub4"},{"key":"10.3238\/arztebl.m2026.0032_ref14","doi-asserted-by":"crossref","unstructured":"T\u00fcrk S, Korfmacher AK, Gerger H, van der Oord S, Christiansen H: Interventions for ADHD in childhood and adolescence: A systematic umbrella review and meta-meta-analysis. Clin Psychol Rev 2023; 102: 102271.","DOI":"10.1016\/j.cpr.2023.102271"},{"key":"10.3238\/arztebl.m2026.0032_ref15","unstructured":"Wolraich ML, Hagan JF Jr., Allan C, et al.: Clinical Practice Guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. Pediatrics 2019; 144: e20192528."},{"key":"10.3238\/arztebl.m2026.0032_ref16","unstructured":"Banaschewski T: S3-Leitlinie: ADHS bei Kindern, Jugendlichen und Erwachsenen. AWMF online 2021."},{"key":"10.3238\/arztebl.m2026.0032_ref17","doi-asserted-by":"crossref","unstructured":"Weber A, Karch D, Thyen U, et al.: Inanspruchnahme von Ergotherapie im Kindesalter\u2013Ergebnisse aus der KiGGS-Basiserhebung. Klinische P\u00e4diatrie 2016; 228: 77\u201383.","DOI":"10.1055\/s-0041-111177"},{"key":"10.3238\/arztebl.m2026.0032_ref18","doi-asserted-by":"crossref","unstructured":"Ostinelli EG, Schulze M, Zangani C, et al.: Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: A systematic review and component network meta-analysis. Lancet Psychiatry 2025; 12: 32\u201343.","DOI":"10.1016\/S2215-0366(24)00360-2"},{"key":"10.3238\/arztebl.m2026.0032_ref19","doi-asserted-by":"crossref","unstructured":"Cortese S: Pharmacologic treatment of attention deficit\u2013hyperactivity disorder. N Engl J Med 2020; 383: 1050\u20136.","DOI":"10.1056\/NEJMra1917069"},{"key":"10.3238\/arztebl.m2026.0032_ref20","doi-asserted-by":"crossref","unstructured":"Gosling CJ, Garcia-Argibay M, De Prisco M, et al.: Benefits and harms of ADHD interventions: Umbrella review and platform for shared decision making. BMJ 2025: 391: e085875.","DOI":"10.1136\/bmj-2025-085875"},{"key":"10.3238\/arztebl.m2026.0032_ref21","doi-asserted-by":"crossref","unstructured":"Hahn-Markowitz J, Berger I, Manor I, Maeir A: Efficacy of cognitive-functional (Cog-Fun) occupational therapy intervention among children with ADHD: An RCT. J Atten Disord 2020; 24: 655\u201366.","DOI":"10.1177\/1087054716666955"},{"key":"10.3238\/arztebl.m2026.0032_ref22","doi-asserted-by":"crossref","unstructured":"Adamou M, Asherson P, Arif M, et al.: Recommendations for occupational therapy interventions for adults with ADHD: A consensus statement from the UK adult ADHD network. BMC Psychiatry 2021; 21: 72.","DOI":"10.1186\/s12888-021-03070-z"},{"key":"10.3238\/arztebl.m2026.0032_ref23","doi-asserted-by":"crossref","unstructured":"Libutzki B, Ludwig S, May M, Jacobsen RH, Reif A, Hartman CA: Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis. Eur Psychiatry 2019; 58: 38\u201344.","DOI":"10.1016\/j.eurpsy.2019.01.019"},{"key":"10.3238\/arztebl.m2026.0032_ref24","doi-asserted-by":"crossref","unstructured":"Song P, Zha M, Yang Q, Zhang Y, Li X, Rudan I: The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. J Glob Health 2021; 11: 04009.","DOI":"10.7189\/jogh.11.04009"},{"key":"10.3238\/arztebl.m2026.0032_ref25","doi-asserted-by":"crossref","unstructured":"Fayyad J, Sampson NA, Hwang I, et al.: The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Atten Defic Hyperact Disord 2017; 9: 47\u201365.","DOI":"10.1007\/s12402-016-0208-3"},{"key":"10.3238\/arztebl.m2026.0032_ref26","doi-asserted-by":"crossref","unstructured":"Dobrosavljevic M, Solares C, Cortese S, Andershed H, Larsson H: Prevalence of attention-deficit\/hyperactivity disorder in older adults: A systematic review and meta-analysis. Neurosci Biobehav Rev 2020; 118: 282\u20139.","DOI":"10.1016\/j.neubiorev.2020.07.042"},{"key":"10.3238\/arztebl.m2026.0032_ref27","doi-asserted-by":"crossref","unstructured":"London AS, Monnat SM, Gutin I: Self-reported ADHD diagnosis status among working-age adults in the United States: Evidence from the 2023 national wellbeing survey. J Atten Disord 2025; 29: 399\u2013410.","DOI":"10.1177\/10870547251319861"},{"key":"10.3238\/arztebl.m2026.0032_ref28","unstructured":"Schlack R, Beyer AK, Beck L, et al.: Differences in frequency between administrative and parent-reported ADHD diagnosis data of children and adolescents taking sociodemographic characteristics into account\u2014results from the consortium project INTEGRATE-ADHD. J Health Monit 2024; 9: e12674."},{"key":"10.3238\/arztebl.m2026.0032_ref29","unstructured":"Pfeifer S, Beyer AK, Beck L, et al.: When do parents report their child\u2018s administrative ADHD diagnosis? A utilisation-based analysis from the consortium project INTEGRATE-ADHD. J Health Monit 2024; 9: e12676."},{"key":"10.3238\/arztebl.m2026.0032_ref30","doi-asserted-by":"crossref","unstructured":"Ivanova M, Holstiege J, Akmatov MK, M\u00fcller D, Kohring C: The incidence of AD(H)D spectrum disorders in adults: An analysis of nationwide claims data of the statutory health insurance system in Germany, 2015\u20132024. Dtsch Arztebl Int 2025; 122: 697\u20138.","DOI":"10.3238\/arztebl.m2025.0167"},{"key":"10.3238\/arztebl.m2026.0032_ref31","doi-asserted-by":"crossref","unstructured":"Li L, Coghill D, Sj\u00f6lander A, et al.: Increased prescribing of attention-deficit\/hyperactivity disorder medication and real-world outcomes over time. JAMA Psychiatry 2025; 82: 830\u20137.","DOI":"10.1001\/jamapsychiatry.2025.1281"},{"key":"10.3238\/arztebl.m2026.0032_ref32","doi-asserted-by":"crossref","unstructured":"Xu G, Strathearn L, Liu B, Yang B, Bao W: Twenty-year trends in diagnosed attention-deficit\/hyperactivity disorder among US children and adolescents, 1997\u20132016. JAMA Netw Open 2018; 1: e181471.","DOI":"10.1001\/jamanetworkopen.2018.1471"},{"key":"10.3238\/arztebl.m2026.0032_ref33","doi-asserted-by":"crossref","unstructured":"Gr\u00f8ntved S, Hald K, Mohr-Jensen C, Johnsen SP, Mainz J, Valentin JB: Prevalence and incidence of attention deficit\/hyperactivity disorder in Denmark. A national register-based open cohort study. Acta Psychiatr Scand 2025; 152: 27\u201338.","DOI":"10.1111\/acps.13804"},{"key":"10.3238\/arztebl.m2026.0032_ref34","doi-asserted-by":"crossref","unstructured":"Khadka N, Peltier MR, Fassett MJ, et al.: Rising trends of childhood attention-deficit\/hyperactivity disorder in a large integrated healthcare delivery system in Southern California, 2010\u20132021. J Pediatr 2024; 269: 113997.","DOI":"10.1016\/j.jpeds.2024.113997"},{"key":"10.3238\/arztebl.m2026.0032_ref35","doi-asserted-by":"crossref","unstructured":"Ellis RP, Hsu HE, Song C, et al.: Diagnostic category prevalence in 3 classification systems across the transition to the international classification of diseases, tenth revision, clinical modification. JAMA Netw Open 2020; 3: e202280.","DOI":"10.1001\/jamanetworkopen.2020.2280"},{"key":"10.3238\/arztebl.m2026.0032_ref36","doi-asserted-by":"crossref","unstructured":"Given J, Paoletti O, Bromley R, et al.: The effect of different algorithms on prevalence of attention deficit hyperactivity disorder and autism spectrum disorder in secondary healthcare data in five European countries: A contribution from the ConcePTION Project. J Autism Dev Disord 2025. Doi: 10.1007\/s10803\u2013025\u201306997\u20134. Online ahead of print.","DOI":"10.1007\/s10803-025-06997-4"},{"key":"10.3238\/arztebl.m2026.0032_ref37","doi-asserted-by":"crossref","unstructured":"Shi Y, Hunter Guevara LR, Dykhoff HJ, et al.: Racial disparities in diagnosis of attention-deficit\/hyperactivity disorder in a US national birth cohort. JAMA Netw Open 2021; 4: e210321.","DOI":"10.1001\/jamanetworkopen.2021.0321"},{"key":"10.3238\/arztebl.m2026.0032_ref38","unstructured":"Abbas S, Ihle P, Adler JB, et al.: Psychopharmacological prescriptions in children and adolescents in Germany\u2014a nationwide analysis of over 4 million statutory insured individuals from 2004 to 2012. Dtsch Arztebl Int 2016; 113: 396\u2013403."},{"key":"10.3238\/arztebl.m2026.0032_ref39","doi-asserted-by":"crossref","unstructured":"Lindemann C, Langner I, Kraut AA, et al.: Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit\/hyperactivity disorder in Germany. J Child Adolesc Psychopharmacol 2012; 22: 307\u201314.","DOI":"10.1089\/cap.2011.0064"},{"key":"10.3238\/arztebl.m2026.0032_ref40","doi-asserted-by":"crossref","unstructured":"Garbe E, Mikolajczyk RT, Banaschewski T, et al.: Drug treatment patterns of attention-deficit\/hyperactivity disorder in children and adolescents in Germany: Results from a large population-based cohort study. J Child Adolesc Psychopharmacol 2012; 22: 452\u20138.","DOI":"10.1089\/cap.2012.0022"},{"key":"10.3238\/arztebl.m2026.0032_ref41","doi-asserted-by":"crossref","unstructured":"Rzeszutek M, Wolańczyk T: Global trends in ADHD medication use: Multiple contexts and rising concerns\u2014a narrative review. J Clin Med 2025; 14: 7338.","DOI":"10.3390\/jcm14207338"},{"key":"10.3238\/arztebl.m2026.0032_ref42","doi-asserted-by":"crossref","unstructured":"Fridman M, Banaschewski T, Sikirica V, Quintero J, Chen KS: Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children\/adolescents with ADHD in Europe: Data from the caregiver perspective on pediatric ADHD survey. Neuropsychiatr Dis Treat 2017; 13: 947\u201358.","DOI":"10.2147\/NDT.S128752"},{"key":"10.3238\/arztebl.m2026.0032_ref43","doi-asserted-by":"crossref","unstructured":"Hinshaw SP, Scheffler RM, Fulton BD, et al.: International variation in treatment procedures for ADHD: Social context and recent trends. Psychiatric Services 2011; 62: 459\u201364.","DOI":"10.1176\/ps.62.5.pss6205_0459"},{"key":"10.3238\/arztebl.m2026.0032_ref44","doi-asserted-by":"crossref","unstructured":"Setyawan J, Fridman M, Grebla R, Harpin V, Korst LM, Quintero J: Variation in presentation, diagnosis, and management of children and adolescents with ADHD across European countries. J Atten Disord 2018; 22: 911\u201323.","DOI":"10.1177\/1087054715597410"},{"key":"10.3238\/arztebl.m2026.0032_ref45","doi-asserted-by":"crossref","unstructured":"Sibley MH, Link K, Torres Antunez G, Greenwood L: Engagement barriers to behavior therapy for adolescent ADHD. J Clin Child Adolesc Psychol 2023; 52: 834\u201349.","DOI":"10.1080\/15374416.2022.2025597"},{"key":"10.3238\/arztebl.m2026.0032_ref46","doi-asserted-by":"crossref","unstructured":"Gajria K, Lu M, Sikirica V, et al.: Adherence, persistence, and medication discontinuation in patients with attention-deficit\/hyperactivity disorder\u2014a systematic literature review. Neuropsychiatr Dis Treat 2014; 10: 1543\u201369.","DOI":"10.2147\/NDT.S65721"},{"key":"10.3238\/arztebl.m2026.0032_ref47","doi-asserted-by":"crossref","unstructured":"Jaite C, Hoffmann F, Seidel A, Mattejat F, Bachmann C: Ambulante psychotherapeutische Versorgung von Kindern und Jugendlichen in Deutschland: Status quo und Trends im Zeitraum 2009\u20132018. Psychiatr Prax 2021; 49: 304\u201312.","DOI":"10.1055\/a-1540-4958"},{"key":"10.3238\/arztebl.m2026.0032_ref48","doi-asserted-by":"crossref","unstructured":"Riedel O, Klau S, Langner I, Bachmann C, Scholle O: Prevalence of multimodal treatment in children and adolescents with ADHD in Germany: A nationwide study based on health insurance data. Child Adolesc Psychiatry Ment Health 2021; 15: 76.","DOI":"10.1186\/s13034-021-00431-0"},{"key":"10.3238\/arztebl.m2026.0032_ref49","doi-asserted-by":"crossref","unstructured":"Andersohn F, Walker J: Characteristics and external validity of the German Health Risk Institute (HRI) database. Pharmacoepidemiol Drug Saf 2016; 25: 106\u20139.","DOI":"10.1002\/pds.3895"},{"key":"10.3238\/arztebl.m2026.0032_ref50","doi-asserted-by":"crossref","unstructured":"Ludwig M, Enders D, Basedow F, Walker J, Jacob J: Sampling strategy, characteristics and representativeness of the InGef research database. Public Health 2022; 206: 57\u201362.","DOI":"10.1016\/j.puhe.2022.02.013"},{"key":"10.3238\/arztebl.m2026.0032_ref51","doi-asserted-by":"crossref","unstructured":"Swart E, Bitzer EM, Gothe H, et al.: A consensus German reporting standard for secondary data analyses, version 2 (STROSA-STandardisierte BerichtsROutine f\u00fcr Sekund\u00e4rdatenAnalysen). Gesundheitswesen 2016; 78 (S 01): e145\u2013e60.","DOI":"10.1055\/s-0042-108647"},{"key":"10.3238\/arztebl.m2026.0032_ref52","doi-asserted-by":"crossref","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007; 370 (9596): 1453\u20137.","DOI":"10.1016\/S0140-6736(07)61602-X"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2026.0032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T09:44:37Z","timestamp":1778147077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2026.0032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":52,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2026.0032","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]}}}